Women who don't have BRCA mutations could have other high-risk genes that affect treatment choices
This news article has expired. Below you will find a short description about the news article and comments that were left by CancerCompass users.
Renewing prior recommendations, experts say current tests may do more harm than good
Thu May 24, 2012 08:52 PM
It is disappointing to hear this recommendation. I have ovarian cancer and highly recommend a CA125 to everyone I can. If it's false positive, it can be rechecked, if it is positive it will save you from a certain death. It's not expensive and a simple blood test. Although the doctors do not like to give CA125 even to people in remission, I insist on it and it has resulted in me knowing the cancer is back and letting me make the decision for care. I know they say having chemo when the 125 is elevated or waiting for the symptoms to appear has no effect on success, this is the only way I can be part of my wellness and emotional wellbeing. I'm not saying to have this test yearly but if you have any nausea that won't go away and are bloating, it only takes a minute to find out if your level has risen from the norm. How many women have to die before the costs become secondary to life.
We care about your feedback. Let us know how we can improve your CancerCompass experience.